Association of De Novo <i>RNF213</i> Variants With Childhood Onset Moyamoya Disease and Diffuse Occlusive Vasculopathy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33568546.
- Also identified by DOI 10.1212/WNL.0000000000011653 and PMC identifier 8055312.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To test the hypothesis that de novo genetic variants are responsible for moyamoya disease (MMD) in children with unaffected relatives, we performed exome sequencing of 28 affected children and their unaffected parents. Exome sequencing was performed on 28 trios of affected patients with MMD and unaffected parents. We identified 3 novel rare de novo <i>RNF213</i> variants, 1 in the RING domain and 2 in a highly conserved region distal to the RING domain (4,114-4,120). These de novo cases of MMD present at a young age with aggressive MMD and uniquely have additional occlusive vascular lesions, including renal artery stenosis. Two previously reported cases had de novo variants in the same limited region and presented young with aggressive MMD, and 1 case had narrowing of the inferior abdominal aorta. These results indicate a novel syndrome associated with <i>RNF213</i> rare variants defined by de novo mutations disrupting highly conserved amino acids in the RING domain and a discrete region distal to the RING domain delimited by amino acids 4,114 to 4,120 leading to onset of severe MMD before 3 years of age and occlusion of other arteries, including the abdominal aorta, renal, iliac, and femoral arteries.
Medical subject headings
- Adenosine Triphosphatases
- Moyamoya Disease
- Ubiquitin-Protein Ligases